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Intravenous catheterization is a necessity for continuous 
administration of intravenous fluids and for intermittent 
intravenous access to avoid discomfort and potential 
complications of repeated needle insertions into the 
vein. Intravenous catheterization is commonly per-
formed and well tolerated in horses, but catheter asso-
ciated complications have been reported. The most 
commonly reported complication is thrombophlebitis, 
but others such as venous air embolism, exsanguination 
and catheter fragmentation may also occur. This article 
aims to review clinical signs, pathogenesis, diagnosis, 
therapy, risk factors and prevention of common catheter 
associated complications. 
Keywords: thrombophlebitis, catheter fragmentation,  
exsanguination, venous air embolism
Katheter-assoziierte Komplikationen 
bei Pferden
Das Legen eines peripher-venösen Katheters ist eine 
wichtige Massnahme bei Pferden um Infusionen konti-
nuierlich verabreichen zu können. Wenn ein intermit-
tierender intravenöser Zugang benötigt wird, verhindert 
ein peripher-venöser Katheter eine Traumatisierung der 
Vene durch wiederholte Nadeleinstiche. Peripher-venö-
se Katheter werden häufig gesetzt und von Pferden gut 
toleriert, jedoch kann es auch zu Komplikationen kom-
men. Am häufigsten ist Thrombophlebitis beschrieben, 
aber auch venöse Luftembolien, Fragmentation von 
Kathetern und Verbluten kommen vor. Dieser Artikel 
zielt darauf ab, die Symptome, Pathogenese, Diagnose, 
Therapie, Risikofaktoren und Prävention von häufigen 
Katheter-assoziierten Komplikationen bei Pferden zu 
beschreiben. 
Schlüsselwörter: Thrombophlebitis, Verbluten, venöser 
Luftembolus, Katheterfragmentation
Introduction
Intravenous access for administration of medication, 
blood collection and intravenous fluid therapy is an 
important aspect of therapy in sick horses. Intravenous 
catheterization is commonly performed and well toler-
ated in horses. However, it may also lead to complica-
tions, which will be reviewed in this article. Information 
on clinical signs, pathogenesis, diagnosis, therapy, risk 
factors and prevention will be discussed. 
Thrombophlebitis
Several clinical pictures are commonly grouped under 
thrombophlebitis. Peri- or paraphlebitis is defined as 
inflammation of the vein and surrounding tissue and 
can be septic or aseptic. Thrombophlebitis is defined as 
an inflammation of the vessel wall followed by forma-
tion of a thrombus in the lumen of the vein, which can 
be septic or aseptic. Vein thrombosis refers to the pres-
ence of a thrombus without concurrent mural inflam-
mation; it often represents the long-term outcome of 
thrombophlebitis (Spurlock et al., 1990; Divers, 2003). 
Occurrence rate of thrombophlebitis has been reported 
as 1–29%. Horses undergoing elective surgical pro-
cedures have the lowest rate of occurrence of thrombo-
phlebitis, while horses with systemic inflammatory 
disease have the highest rates (Gulick and Meagher, 
1981; Spurlock et al., 1990; Traub-Dargatz and Dargatz, 
1994; Lankveld et al., 2001; Mair and Smith, 2005; 
Geraghty et al., 2009). 
Pathogenesis
Horses have a coagulation system, which tends towards 
hypercoagulability in disease states, leading to excessive 
activation of coagulation, impairment of fibrinolysis 
and anticoagulant pathways, resulting in thrombosis 
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eter dwell time and catheter material have an influence 
on local trauma to the vein. Rigid materials have a great-
er potential for causing endothelial damage (Spurlock 
et al., 1990). Horses with systemic disease, particularly 
gastrointestinal disease, have an increased risk of devel-
oping thrombophlebitis. Horses that had antimicrobials 
or non-steroidal anti-inflammatory medication admin-
istered through the catheter had a lower risk of thrombo-
phlebitis compared to horses that did not have these 
medications administered (Traub-Dargatz and Dargatz, 
1994; Geraghty et al., 2009). Administration of irritating 
medication and total parenteral nutrition are also com-
mon risk factors for thrombophlebitis. Foals have a 
higher risk of catheter associated problems compared to 
adults (Ettlinger et al., 1992). As common sources of 
bacterial contamination are the skin of horses or noso-
comial pathogens from the hospital environment. Ani-
mals which are recumbent or spend a larger than normal 
time in recumbency are at higher risk of septic thrombo-
phlebitis (foals, sick animals, colics) (Gardner et al., 
1991; Ettlinger et al., 1992).
Clinical signs and diagnosis of thrombo-
phlebitis
Diagnosis is made based on clinical signs, ultrasono-
graphic examination and blood work. Clinical signs 
often appear 24–48h after removal of a catheter, or while 
the catheter is still in place (Lankveld et al., 2001). 
Thrombosis usually starts at the insertion site or the tip 
of the catheter. Clinical signs include pain, heat or swell-
ing of the vein, firmness ‘rope like appearance and feel 
of the vein’ and lack of fill in the vein distal to the 
catheter (Fig. 1 A and B). Swelling of the surrounding 
tissue and head may also occur. Often fever appears as 
a first clinical sign but can also occur later in the course 
of the disease. Limb edema and cellulitis are seen in 
association with cephalic vein thrombosis. 
Acute phase proteins such as fibrinogen and serum amyl-
oid A as well as leukocytes and neutrophils are often 
elevated (Westerman et al., 2016). Patients with any of 
the clinical signs, fever or unexplained leukocytosis 
(neutrophilia) or elevated acute phase proteins should 
have their catheterized vein evaluated immediately by 
clinical examination and ultrasound. 
(Dunkel et al., 2010; Mendez-Angulo et al., 2011). Vir-
chow described the three factors leading to thrombus 
formation (Virchow’s triad). These include local trauma, 
reduced blood flow and altered coagulation status. Cath-
eter insertion leads to minor trauma and inflammation 
of the vein, followed by activation of the coagulation 
cascade. Sick horses often spend a lot of time with their 
head in a lower position than normal contributing to 
abnormal blood flow in the vein. This increases the risk 
of coagulopathies (Divers, 2003). Most cases of throm-
bophlebitis in a hospital setting are non-septic. If bac-
terial infection of the thrombus occurs, environmental 
or skin bacteria will colonize the thrombus, rather than 
hematogenous infection of the thrombus. The catheter 
insertion site serves as a portal for bacteria and rarely 
fungi to gain access to the vein (Geraghty et al., 2009). 
The most common bacteria isolated are Staphylococcus 
spp., Enterobacter spp. and Streptococcus spp. (Ettlinger et 
al., 1992; Lankveld et al., 2001; Geraghty et al., 2009). 
Drug resistant bacteria have also been cultured from 
septic thrombi of horses, highlighting the need for cul-
ture and sensitivity profiles (Gardner et al., 1991). Bac-
teria can be cultured from 50–60% of removed catheters 
tips from horses with signs of thrombophlebitis, how-
ever bacteremia and sepsis are rare (Gardner et al., 1991; 
Ettlinger et al., 1992; Tan et al., 2003). Bacterial colon-
ization of the catheter tip does not always correlate with 
clinical signs of thrombophlebitis. Particularly Acineto-
bacter baumanii and other Gram-negatives can frequent-
ly be cultured from catheter tips without associated signs 
of venous disease, highlighting the need of a clinical 
diagnosis (Ettlinger et al., 1992; Vaneechoutte et al., 
2000; Geraghty et al., 2009; Milne and Bradbury, 2009). 
Secondary complications of thrombophlebitis include 
bacteremia, septicemia and dislodging of thrombi lead-
ing to pulmonary thromboembolism, endocarditis and 
infarctive pleuropneumonia (Tan et al., 2003; Ryu et al., 
2004; Aksoy et al., 2008). 
Risk factors
Risk factors include catheter-associated factors, patient 
factors and medication administered (Tab. 1) (Dickson 
et al., 1990; Spurlock et al., 1990; Meister et al., 1993; 
Traub-Dargatz and Dargatz, 1994; Lankveld et al., 2001; 
Dolente et al., 2005; Geraghty et al., 2009). Both cath-
Table 1: Risk factors for development of thrombophlebitis after intravenous catheterization in horses.
Catheter factors Improper  
placement
Diameter Flexibility Composition Dwell time
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Ultrasonography examination is useful to characterize 
the extent and monitor the progression of the disease. 
Ultrasound can be used to detect catheter related abnor-
malities that are not yet clinically evident. Serial exam-
inations are often useful as changes might not be obvi-
ous on the first examination but become more 
pronounced 12–24 hours later (Geraghty et al., 2009). 
A linear transducer with 7.5 or 10-11 MHz, shallow 
depth and focal point should be used. For better visu-
alization the horse should be clipped and alcohol or 
ultrasound gel applied to the area. The vein should be 
evaluated in transverse and longitudinal planes along 
its entire length while it is filled and under physiologic 
conditions. Special attention should be paid to the cath-
eter entrance site as well as tip of the catheter. The nor-
mal jugular vein is a circular hypoechoic structure on 
transverse section, and tubular structure in a longitu-
dinal view, surrounded by a slightly more hyperechoic 
wall. Thickening of the wall, surrounding tissue edema, 
fluid accumulation, gas as well as thrombi can be iden-
tified in case of thrombophlebitis (Fig. 2 A and B). A 
thrombus is a homogenous hyperechoic mass attached 
to the vessel wall on at least one side and protruding 
into the lumen (Fig. 3 A). Blood flow can be imaged past 
the thrombus if it is only partially occlusive using pulsed 
wave or color-coded Doppler (Fig. 3 B). Thrombosis can 
extend to involve the external maxillary vein and the 
linguofacial vein cranially or extend down the thoracic 
inlet caudally (Gardner et al., 1991; Geraghty et al., 
2009). A septic thrombus is a cavitated heterogeneous 
mass, fully or partially obstructing the vein. The an-
echoic areas represent fluid accumulation secondary to 
infection.. (Gardner et al., 1991). A needle aspirate of 
the fluid cavity for bacterial culture and gram stain can 
be performed after aseptically preparing the site. 
Treatment 
If the catheter is still in place when the diagnosis is 
made, it should be removed. The catheter site should be 
aseptically prepared and the catheter removed in a ster-
ile procedure. The tip of the catheter should be cut off 
with sterile scissors and a culture (aerobic and anaerobic) 
and sensitivity profile performed.
Thrombus development occurs mostly in the first 24h 
of injury, therefore treatment should be instituted as 
early as possible (Dias and Neto, 2013). The choice of 
treatment depends on the severity of the disease and 
centers on decreasing the present inflammation, pre-
venting formation of or dissolving an existing thrombus 
and preventing or treating secondary bacterial infection. 
Independent of the severity of the disease the affected 
vein should no longer be used for venipuncture. 
Local therapy includes hydrotherapy and hot packs, 
application of anti-inflammatory ointments and DMSO. 
Figure 3: Mural thrombus in a jugular vein in transverse section (A) and blood 
flow around the thrombus visualized using color coded Doppler (B).
Figure 2: Typical changes associated with thrombophlebitis in a jugular vein by 
ultrasound in transverse (A) and longitudinal section (B). Note the thickening  
of the vessel wall (arrow with two heads), perivascular edema (thin arrow) and 
the thrombus adhered to the vessel wall (thick arrow). CA: Carotid artery,  
JV: jugular vein.
Figure 1: Focal swelling of the jugular vein (A) and ‘Rope-like’ appearance of the 
jugular vein of a horse with thrombophlebitis (B).
If the thrombophlebitis is extensive and clinical or 
ultrasonographic signs of a septic thrombus are present, 
systemic treatment should be instituted. Anti-inflam-
matory medication should be used to reduce signs of 
inflammation (flunixin meglumin 1.1mg/kg IV q12h, 
meloxicam 0.6mg/kg PO or IV q24h). Broad-spectrum 
antimicrobials such as penicillin (Na-Penicillin 
30.000IU/kg IV q6h) combined with aminoglycoside 
(gentamicin 6.6mg/kg IV q24h), or trimethoprimsul-
fa-methoxazole (24mg/kg PO q12h) are indicated to 
prevent or treat bacterial infection. If a culture and sen-
sitivity profile were performed, antimicrobial therapy 
should be adjusted accordingly. Anaerobic bacteria were 
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cultured from 8% of septic thrombi in one study (Gard-
ner et al., 1991). If anaerobic infection is suspected based 
on the presence of gas on ultrasound, antimicrobials 
with anaerobic action need to be chosen. Metronidazol 
(25mg/kg PO, q12h) is effective, but its use is only per-
mitted in non-food producing animals in Switzerland. 
Penicillin (Na-Penicillin 30.000IU/kg IV q6h) or oxy-
tetracycline (7mg/kg IV q 12h) can be used alternative-
ly. Systemic treatment should be continued for several 
days until the clinical signs of inflammation have sub-
sided and inflammatory changes on blood work have 
normalized. On ultrasound the thrombus should appear 
unchanged over several days and gas should be absent 
before treatment is discontinued. 
To prevent formation of a thrombus or attempt to re-
solve an existing thrombus local and systemic therapy 
can be attempted. Local treatment with heparinized 
creams can be attempted, however high concentrations 
of heparin are needed to achieve similar levels in the 
corium compared to intravenous application of heparin. 
Low molecular weight heparin (50-100IE/kg, SQ , q24h) 
had a better clinical effect than heparin (40-100IE/Kg, 
IV or SQ q6h) for prevention of thrombophlebitis and 
was associated with fewer adverse effects (Schwarzwald 
et al., 2002; Feige et al., 2003). Acetylsalicylic acid, a 
prostaglandin inhibitor, reduces thrombocyte aggrega-
tion and can be used at a dose of 20mg/kg PO q48h. 
Treatment duration depends on the severity of the 
thrombus and financial means of the owner. Treatment 
should be discontinued once the thrombus does not 
appear to grow and clinical signs of inflammation have 
subsided. 
Other anticoagulants (phenoprocoumon, warfarin, clo-
pridogel) have been studied but are difficult to admin-
ister in a practice setting due to monitoring requirements 
or they have only been evaluated in a research setting 
(Scott et al., 1980; Bubeck et al., 2005; Brainard et al., 
2011; Brainard et al., 2012). Recombinant tissue plas-
minogen activator has recently been evaluated in vivo 
and in vitro for its thrombolytic effects in healthy hors-
es. While initial results appear promising more studies 
are needed to evaluate the safety and effectiveness 
(Baumer et al., 2013). 
In case of fluid accumulation around the vein, drainage 
should be established. Often a small skin nick is suffi-
cient (Fig. 4). In severe cases, surgical treatment is ne-
cessary to remove accumulation of necrotic tissue and 
infected material from the vein and surrounding area. 
Phlebotomy, thrombectomy or venous grafts can be 
performed to remove infected thrombi and restore 
blood flow in selected cases (Cannon, 1983; Rijkenhui-
zen and van Swieten, 1998; Wiemer et al., 2005; Russell 
et al., 2010). 
Prognosis
The outcome of thrombophlebitis is variable. The 
thrombus may undergo recanalization and blood flow 
may be partially restored. If the vein becomes fully oc-
cluded, collateral vessels will form after some time. The 
affected vein should not be used in the future for injec-
tions or catheterizations. Thrombophlebitis did not 
affect the horses’ performance on a pleasure riding and 
show horse level, even when occlusion was bilateral. 
However, in racing Standardbreds thrombophlebitis was 
associated with a decreased chance of return to racing 
(Moreau and Lavoie, 2009)
Prevention
Careful selection of an appropriate vein and catheter 
type is imperative. In horses the jugular veins are most 
commonly used for peripheral venous access. Both jugu-
lar veins should be patent and without signs of inflam-
mation. If one of the jugular veins shows signs of pre-
exist ing disease, an alternative to the jugular veins should 
be considered for catheterization to avoid the potential 
life threatening complication of bilateral thrombophle-
bitis. The lateral thoracic vein, cephalic vein or saphe-
nous vein are alternatives for placement of an indwelling 
intravenous catheter. If parenteral nutrition is planned, 
a large vein (lateral thoracic or jugular) should be used 
to minimize endothelial irritation. Polyurethane cathe-
ters should be used if saphenous veins, cephalic veins or 
the lateral thoracic veins are used (Divers, 2003). 
There are no guidelines regarding optimal site prepara-
tion for catheter placement. Independent of the product 
used, disinfection results in decreased bacterial contam-
Figure 4: Thrombophlebitis in a horse with established drainage through a small nick in 
the ventral aspect.
477_486_Schoster.indd   480 25.08.17   12:42
Übersichtsarbeiten | Reviews
481SAT | ASMV 9 | 2017Band 159, Heft 9, September 2017, 477–485, © GST | SVS
Complications of intra­
venous catheterization  
in horses
A. Schoster
ination of the skin (Hague et al., 1997; Zubrod et al., 
2004; Geraghty et al., 2009). The hair coat can be 
clipped, shaved or left long (Hague et al., 1997; Geraghty 
et al., 2009). Clipping, but not disinfection, can be omit-
ted if rapid intravenous catheterization is necessary. 
Clipping is still recommended if time permits, as foreign 
material can easily be introduced with the long hair coat. 
The vein is more easily visible when the coat is clipped, 
which can help prevent additional trauma due to im-
proper placement (Geraghty et al., 2009). 
The following ranking order of decreasing thrombo-
genicity of catheter material commonly used has been 
established: polyethylene (including teflon), polyur-
ethane and silastic. (Spurlock et al., 1990; Aksoy et al., 
2008). Catheter type has less influence on development 
of thrombophlebitis in horses compared to humans, and 
patient factors as well as dwell times play a bigger role 
(Dickson et al., 1990; Lankveld et al., 2001; Milne and 
Bradbury, 2009). The rigidity of Teflon (polytetrafluoro-
ethylene) catheters causes more vessel wall irritation and 
increases the risk of thrombophlebitis. They can be 
introduced over a needle or stylet and usually lie against 
the vessel wall. Polyurethane or silicone catheters are 
less rigid, and cause fewer traumas to the vessel wall. 
Due to their flexibility they have to be introduced with 
an over the wire or peel away technique, which require 
fastidious aseptic technique and skill. They usually lie 
within the vessel lumen, further decreasing the risk of 
wall trauma (Spurlock et al., 1990). To further reduce 
thrombogenicity catheters should be of adequate length 
(20–30 cm). Shorter catheters are prone to more move-
ment and inducing trauma to the vessel wall (Spurlock 
et al., 1990). While there is not enough evidence in the 
horse to prove that catheter diameter is associated with 
thrombophlebitis, this is a known risk factor in humans. 
The size of the lumen should be adequate for the desired 
fluid rate but not too large (Traub-Dargatz and Dargatz, 
1994). For adult middle and large sized horses 14G cath-
eters are recommended, if large volumes of fluid have 
to be administered 8G–12G can be used. For foals and 
smaller horses 14G and 16G can be used. In foals, small 
horses and systemically compromised patients long-term 
over the wire polyurethane catheters should be used to 
avoid dislodging, kinking and other complications. 
Double lumen catheters should be restricted to horses 
receiving parenteral nutrition. The correct procedure of 
catheter insertion and securing depends on the type of 
catheter used and is beyond the scope of this review. An 
excellent summary is given by Barakzai and Chandler 
(2003). 
Dwell times of catheters are much longer in human 
medicine compared to horses. Short-term catheters 
made of teflon should remain in the vein for a maximum 
of 2–3 days (Lankveld et al., 2001). Long-term catheters 
made of polyurethane or silicon can remain in the vein 
for up to 1–2 months if no signs of inflammation are 
present. Indwelling catheters should be assessed twice 
daily for signs of developing inflammation (Divers, 
2003). In addition to clinical examination, ultrasound 
should be used periodically to detect early signs of dis-
ease, particularly in high-risk patients (Geraghty et al., 
2009). Catheters should be flushed every 4–6h with 
saline if not used. Whether or not the addition of hep-
arin (1–10IE Heparin/mL) is needed is debated but it is 
commonly added. An extension should be connected 
to the catheter permanently to avoid constant manipu-
lation of the catheter. A bandage should not be placed 
over the catheter to easily identify problems and prevent 
problems with blood circulation. Foals might need a 
bandage placed around the catheter to avoid them tem-
pering with the catheter. When injecting medication 
through the medication cap, the catheter cap should be 
wiped with alcohol prior to insertion of the needle. The 
injection cap should be changed daily. The catheterized 
vein should not be used for venipuncture. Catheters 
placed in saphenous, cephalic or lateral thoracic veins 
should be flushed every 4 hours and protected by ban-
dages to prevent trauma to the catheters (Barakzai and 
Chandler, 2003). 
Venous air embolism
Iatrogenic air embolism following inadvertently left 
open jugular venous lines have been reported (Bradbury 
et al., 2005; Holbrook et al., 2007; Sams and Hofmeister, 
2008). Air enters into the venous circulation due to the 
negative pressure compared to the atmospheric pressure. 
Small amounts of air likely do not result in clinical signs 
in horses. If large amounts of air enter the circulation, 
air emboli travel through the right heart into the lung 
circulation causing cardiac and pulmonary signs. Pul-
monary edema develops due to hypoxemia, hypoten-
sion, increased vascular permeability and acute inflam-
mation. Cardiac output can be reduced due to embolism. 
The only scientific report on the amount of intravenous 
air tolerated in horses is a volume of up to 0.25 mL/kg 
before clinical symptoms occur (Muir, 1991). Microbub-
bles diffuse through the alveolar membrane and are 
exhaled. If the amount of air exceeds the filter capacity 
of the lungs the air gains access to the systemic arterial 
circulation and can then be distributed to all organs. 
Air emboli in the coronary and cerebral circulation can 
be associated with severe clinical signs (Pellegrini-Mas-
ini et al., 2009). 
Clinical signs
Clinical signs vary depending on the organ system af-
fected by the air embolus. Horses show signs of cardio-
vascular collapse, cardiac dysrhythmias, cardiac mur-
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murs (mill-wheel murmur), tachycardia, tachypnea, 
pulmonary edema, behavioral abnormalities and neuro-
logical signs (seizures) (Pellegrini-Masini et al., 2009). 
Diagnosis
Diagnosis can be made based on history (open venous 
line), and clinical signs. Air embolism can be confirmed 
on echocardiography or Doppler technologies. During 
anesthesia volumetric capnography can be used to diag-
nose venous air embolism (Sacks and Mosing, 2016). 
Treatment
Treatment is mostly symptomatic. Intranasal oxygen 
should be provided to counteract signs of organ hypo-
perfusion. Intranasal oxygen therapy (8L/min intranasal) 
also favors clearance of air bubbles. Intravenous fluid 
therapy should be considered to support cardiovascular 
function. The use of corticosteroids has been questioned 
since these drugs aggravate ischemic injury and are not 
effective to treat cerebral edema (Muth and Shank, 2000). 
If seizures occur they should be controlled using diaze-
pam (0.05mg/kg IV). If a venous air embolus occurs 
during anesthesia, treatment should include instituting 
intermittent positive-pressure ventilation, administering 
intravenous fluids and increasing the inspired oxygen 
percentage (Sams and Hofmeister, 2008). In human 
medi cine additional measures such as aspiration of air 
using a right atrium catheter, hemodynamic support with 
dobutamine or norepinephrine, mannitol and hyperbar-
ic oxygen therapy have been reported to have favorable 
outcomes. There is increasing evidence for the use of li-
docaine due to its neuroprotective effects (1.3ug/kg/min 
IV continuous rate infusion) (Muth and Shank, 2000).
Prognosis
In the available case reports, all horses recovered from 
venous air embolism and survived without long-term 
complications (Pellegrini-Masini et al., 2009). A one-way 
valve can be used to prevent air entering the catheter if 
the catheter extension or injection cap is lost. 
Catheter fragmentation
Fragmentation of intravenous catheters made of teflon 
has been reported (Spurlock et al., 1990; Scarratt et al., 
1997). When an over the wire technique is used for 
catheter placement, the wire can be lost if the technique 
is faulty. While there is only one case report (Nannarone 
et al., 2013) describing this complication in horses, in 
the authors’ opinion this complication occurs more 
often than reported. Catheter fragments or the guide-
wire can travel through the heart and become lodged in 
the pulmonary vasculature. In smaller animals such as 
ponies and foals the fragments can become lodged in 
the right heart. 
Clinical signs
Catheter fragments or wires often do not cause signs of 
clinical disease. Potential complications include pul-
monary embolism, cardiac arrhythmias, endocarditis, 
septic thrombosis of the wire, and cardiac tamponade 
if it penetrated the heart. 
Treatment
If the fragment or wire is not associated with signs of 
disease it can be left in the horse. The location can be 
assed using ultrasonography and radiography (Lees et 
al., 1989; Ames et al., 1991; Scarratt et al., 1997; Little 
et al., 2002; Culp et al., 2008; Nannarone et al., 2013). 
Fragments and wires have been retrieved successfully in 
some instances using surgical and non-surgical ap-
proaches in adults and foals (Ames et al., 1991; Hoskin-
son et al., 1991; Scarratt et al., 1997; Culp et al., 2008; 
Nannarone et al., 2013). For intravascular retrieval tech-
niques, fluoroscopic guidance is advised, but ultrasound 
guidance can be attempted if the fragment or wire is 
located in the heart. In the described non-surgical ap-
proaches the fragments or wire were retrieved using a 
basket or four pronged retrieval catheter or retrieval 
snare inserted through the jugular vein and a small phle-
botomy to remove the fragments or wire (Ames et al., 
1991; Hoskinson et al., 1991; Culp et al., 2008; Nan-
narone et al., 2013). Surgical techniques describing the 
retrieval of catheter fragments have also been reported 
(Lees et al., 1989). Complications include further frag-
mentation of the catheter, embolization and cardiac 
arrhythmias (Hoskinson et al., 1991). 
Prognosis
In humans there is a fatal outcome in 20% of cases 
(Heberer et al., 1984). It is likely that the situation in 
horses is different, as no deaths due to loss of guidewires 
have been reported. 
Prevention
To minimize the risk of catheter breakage the catheter 
insertion site should be monitored daily for signs of 
catheter kinking or patient induced trauma to the cath-
eter. The stylet or needle should never be reintroduced 
into the catheter to avoid cutting of the catheter with 
the sharp end of the stylet. If a catheter does break in-
advertently during removal or introduction the vein 
should immediately be held off to prevent fragments 
from travelling caudally.
Perivascular leakage
If the catheter is not introduced correctly, dislodges or 
cracks at the insertion site administered medication can 
leak into the surrounding tissue. Shorter catheters are 
more likely to become dislodged (Scarratt et al., 1997). 
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This is not a significant problem when isotonic fluids 
are used. Mild to severe cellulitis can occur when irri-
tating medication is used. Clinical signs consistent with 
cellulitis, such as pain, swelling and heat develop. 
Horner syndrome can occur if the inflammation affects 
the sympathetic branches and ganglia. Some horses be-
come unable to swallow due to inflammation or develop 
laryngeal hemiplegia due to damage to the vagus nerve. 
Infusions should be stopped and the catheter removed. 
Isotonic fluids will be absorbed from the subcutaneous 
area. Subcutaneous infiltration with isotonic fluids such 
as saline can be performed to dilute irritating medica-
tions. Warm compresses and local anti-inflammatory 
treatment should be instituted. Systemic antimicrobial 
and anti-inflammatory therapy and ventral drainage and 
flushing may become necessary in severe cases (see treat-
ment of thrombophlebitis). Prognosis depends on the 
severity of the disease. 
Exsanguination
Exsanguination from a disconnected infusion port or 
catheter cap is a rare occurrence and more likely if there 
is an underlying coagulopathy (Tan et al., 2003). Small-
er patients with less total amount of circulating blood 
volume are at higher risk of exsanguination, e.g. ponies 
or foals. Horses can generally lose 20–30% of their 
blood volume (2 ml/kg, 6L in a 500kg horse) without 
hypotension and corresponding clinical signs (Subcom-
mittee et al., 2013). Clinical signs of hypotension in-
clude pale mucous membranes, tachycardia, altered 
mental state and if severe collapse. If a catheter is dis-
lodged and the horse is bleeding from the insertion site, 
the area should be held off until blood clotting occurs. 
A lost catheter cap or infusion port should be replaced 
and adequate amounts of fluid or whole blood transfu-
sions administered as necessary. One-way valves do not 
allow blood to exit the catheter without a syringe or 
infusion port attached and can be attached to catheters 
to prevent this risk in high-risk animals. 
Inadvertent intra-arterial  
catheterization
If a proper technique is not followed or the horse moves 
during catheter placement inadvertent intra-arterial 
catheterization can occur. In this case, arterial blood is 
seen spurting from the catheter in a pulsatile fashion. 
Arterial blood is lighter in color than venous blood. If 
it is unclear whether the vein or the artery has been 
catheterized a blood gas can be performed to ascertain 
placement of the catheter in the vein. Arterial catheter-
ization is not associated with any problems as long as 
no medication is administered. The catheter should be 
removed, the artery held off for at least 5 minutes to 
prevent formation of hematoma and another catheter 
placed intravenously. If medication is administered 
through an intra-arterial catheter the horse will react 
with violent behavior, collapse and seizures. The cath-
eter should be removed immediately and venous access 
established for treatment. To prevent inadvertent ar terial 
catheterization the horse should be restrained adequate-
ly and prevented from moving its head and neck during 
catheter placement, inexperienced people need to be 
guided by experienced people and the correct location 
for catheter placed should be chosen. The vein and ar-
tery are further apart in the junction of the upper and 
middle third of the neck, which is the correct site for 
catheter placement. 
Conclusion
Complications due to intravenous catheterization can 
occur. The risk may be minimized by careful catheter 
type selection and planning when inserting a catheter 
and optimizing management of indwelling intravenous 
catheters. 
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Complications lors de cathétérisme 
veineux chez le cheval
Le cathétérisme veineux est une nécessité pour l’admi-
nistration continue de fluides par voie intraveineuse et 
pour garantir un accès veineux intermittent afin d’éviter 
l’inconfort et les complications potentielles liées à la 
pénétration répétée d’une aiguille dans la veine. Le ca-
thétérisme veineux est usuellement pratiqué chez le 
cheval et il est bien toléré mais des complications asso-
ciées sont rapportées. La plus commune d’entre elle est 
la thrombophlébite mais d’autre, telles l’embolie ga-
zeuse, l’exsanguination ou la fragmentation du cathéter 
peuvent aussi survenir. Cet article vise à résumer les 
signes cliniques, la pathogénèse, le diagnostic, le traite-
ment les facteurs de risque et la prévention des compli-
cations communément associées avec le cathétérisme. 
Complicazioni di cateterizzazione  
endovenosa nei cavalli
La cateterizzazione endovenosa è una necessità per la 
continua somministrazione di fluidi per via endoveno-
sa e per l’accesso endovenoso discontinuo alfine di evi-
tare disagi e possibili complicazioni dovute all’inseri-
mento ripetuto di aghi in vena.  La cateterizzazione 
endovenosa è comunemente eseguita e ben tollerata dai 
cavalli ma sono state riportate complicazioni legate al 
catetere. La complicazione maggiormente segnalata è la 
tromboflebite seguono embolia gassosa venosa, dissan-
guamento a frammentazione del catetere.  Questo arti-
colo si propone di esaminare i segni clinici, patogenesi, 
diagnosi, terapia, fattori di rischio e prevenzione dovu-
ti a complicazioni legate all’uso di cateteri.  
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